RADIX PHARMACEUTICALS, INC.

Company Information
Address 13303 Sunny Brooke Place
Room 101
Potomac, MD, -


Information

DUNS: 142006910

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of Small Molecules as Antiprotozoal Agents

    Amount: $1,240,336.00

    DESCRIPTION (provided by applicant): The proposed research focuses on the development of novel therapeutic agents for the prevention and treatment of malaria caused by P. falciparum. A previous Phase ...

    SBIRPhase II2012Department of Health and Human Services
  2. Preclinical Studies of Natural Product Derivatives as Antimalarial Agents

    Amount: $998,181.00

    DESCRIPTION (provided by applicant): This project focuses on the development of a novel therapeutic agent for preventing and treating P. falciparum malaria. A two-year Phase I research has discovered ...

    SBIRPhase II2011Department of Health and Human Services
  3. Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase I2008Department of Health and Human Services
  4. Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.

    Amount: $590,628.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase I2008Department of Health and Human Services
  5. Development of Natural Product as Antimalarial Agent

    Amount: $299,880.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase I2007Department of Health and Human Services
  6. Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents

    Amount: $604,800.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase II2006Department of Health and Human Services
  7. Synthesis and Evaluation of Novel Antimalarial Agents

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this research is to develop drugs that are safe and effective against drug-resistant malaria. Malaria is one of the most common infectious di ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government